Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.

Study summary

This Study is a case control Study conducted with 100 patients with a solid tumor cancer diagnosis (lung, breast, or gynecologic cancer). Records of 50 patients who received treatment plans as standard of care will be abstracted for control data. 50 patients undergoing cancer treatment will receive a treatment plan and report symptoms using Carevive PROmPT™.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedCarevive PROmpt™

The study team can explain what participation involves.

Who it may be forLung Cancer · Breast Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jan 18, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Carevive Systems, Inc.

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: Carevive Systems, Inc.
Interventions being studied: Other: Carevive PROmpt™

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

All participants must be 18 years of age or older.
Subject participants must have a diagnosis of a breast, lung, or gynecologic cancer.
Patients must have completed their navigation visit and received a Treatment Care Plan.
Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
Subjects must be starting or receiving treatment.
All participants must be able to understand English.

Reasons someone may not be able to joinExclusion criteria

Any patient who cannot understand written or spoken English.
Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Mitchell Cancer InstituteMobile, Alabama

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 18, 2022. Always confirm current availability with the study team.

View original record ↗